Thrombospondin in Tumor Microenvironment

Divya Ramchandani1, Vivek Mittal2

  • 1Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.

Insights

Thrombospondins (TSPs) are extracellular matrix proteins with dual roles in cancer, promoting and suppressing tumors. TSP-1, a key TSP, inhibits T cells and Tregs, impacting the tumor microenvironment and offering therapeutic targets.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Thrombospondins (TSPs) are extracellular matrix proteins with diverse roles in physiological and pathological processes.
  • TSPs exhibit context-dependent oncogenic and tumor-suppressive functions due to multiple receptor-binding domains.
  • TSPs are crucial components of the tumor microenvironment, influencing angiogenesis, cell migration, and immune responses.

Purpose of the Study:

  • To explore the multifaceted roles of Thrombospondins (TSPs) within the tumor microenvironment.
  • To discuss the structural domains and functional implications of TSPs in cancer progression and metastasis.
  • To review anti-metastatic therapeutic strategies targeting TSPs.

Main Methods:

  • Literature review of Thrombospondin (TSP) functions in cancer.
  • Analysis of TSP structural domains and their relation to biological activity.
  • Examination of therapeutic approaches utilizing TSP-mimetic peptides and antibody blockade.

Main Results:

  • TSPs possess both tumor-promoting and tumor-suppressive qualities, acting as key regulators in the tumor microenvironment.
  • TSP-1 demonstrates antiangiogenic capacity and mediates immunosuppression by inhibiting T cells and inducing regulatory T cells (Tregs).
  • A potential feedback loop between TGF-β and TSP-1 in tumor growth and inflammation was identified.

Conclusions:

  • Thrombospondins (TSPs) play complex roles in cancer, influencing cell adhesion, migration, angiogenesis, and immune evasion.
  • TSP-1's immunosuppressive functions and antiangiogenic properties make it a significant target for anti-cancer therapies.
  • Targeting TSPs through therapeutic strategies like peptide mimetics or antibody blockade shows promise for anti-metastatic approaches.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.3K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K